Cell death associated with genetic prodrug activation therapy of colorectal cancer
- 17 October 2001
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 174 (1) , 25-33
- https://doi.org/10.1016/s0304-3835(01)00679-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Consequences of Cell DeathThe Journal of Experimental Medicine, 2000
- Apoptosis or necrosis for tumor immunotherapy: what's in a name?Journal of Molecular Medicine, 1999
- Disabled Infectious Single-Cycle Herpes Simplex Virus as an Oncolytic Vector for Immunotherapy of Colorectal CancerHuman Gene Therapy, 1999
- Can immunotherapy by gene transfer tip the balance against colorectal cancer?Gut, 1998
- Rapid adenoviral transduction of freshly resected tumour explants with therapeutically useful genes provides a rationale for genetic immunotherapy for colorectal cancerGene Therapy, 1998
- Cell death and cancer: replacement of apoptotic genes and inactivation of death suppressor genes in therapyGene Therapy, 1998
- Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expressionNature Medicine, 1998
- Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLsNature, 1998
- A Family of Bicistronic Vectors to Enhance Both Local and Systemic Antitumor Effects of HSVtk or Cytokine Expression in a Murine Melanoma ModelHuman Gene Therapy, 1997
- Tolerance, Danger, and the Extended FamilyAnnual Review of Immunology, 1994